当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析 - 现金流量表

尔康制药

(300267)

  

流通市值:50.64亿  总市值:73.43亿
流通股本:14.22亿   总股本:20.63亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,166,866,554.16792,973,373.15335,403,374.851,062,706,428.64
  收到的税费返还7,425,034.26,302,693.65,572,527.3925,874,581.79
  收到其他与经营活动有关的现金25,800,325.686,472,954.013,214,667.87163,674,063.49
  经营活动现金流入小计1,200,091,914.04805,749,020.76344,190,570.111,252,255,073.92
  购买商品、接受劳务支付的现金769,801,663.55584,585,381.69277,036,053.2589,418,175.86
  支付给职工以及为职工支付的现金119,576,739.7983,903,371.5447,599,108.83165,014,824.22
  支付的各项税费37,401,990.0224,868,076.8112,289,296.1769,192,077.73
  支付其他与经营活动有关的现金61,626,673.3366,549,943.1911,414,618.81261,938,289.19
  经营活动现金流出小计988,407,066.69759,906,773.23348,339,077.011,085,563,367
  经营活动产生的现金流量净额211,684,847.3545,842,247.53-4,148,506.9166,691,706.92
二、投资活动产生的现金流量:
  收回投资收到的现金740,000,000340,000,000100,000,000210,434,000
  取得投资收益收到的现金3,331,200.042,898,851.972,668,013.71,899,061.74
  处置固定资产、无形资产和其他长期资产收回的现金净额1,362,974.331,167,927.99340,319.1181,300
  投资活动现金流入小计744,694,174.37344,066,779.96103,008,332.8212,514,361.74
  购建固定资产、无形资产和其他长期资产支付的现金107,779,667.0754,007,926.1929,637,797.69195,599,337.8
  投资支付的现金825,000,000395,000,000-330,202,000
  支付其他与投资活动有关的现金---8,868,000
  投资活动现金流出小计932,779,667.07449,007,926.1929,637,797.69534,669,337.8
  投资活动产生的现金流量净额-188,085,492.7-104,941,146.2373,370,535.11-322,154,976.06
三、筹资活动产生的现金流量:
  取得借款收到的现金463,987,821220,000,000120,000,000546,080,000
  收到其他与筹资活动有关的现金228,600,000190,000,00050,000,000250,000,000
  筹资活动现金流入小计692,587,821410,000,000170,000,000796,080,000
  偿还债务支付的现金457,700,000387,700,000197,700,000401,000,000
  分配股利、利润或偿付利息支付的现金9,430,610.045,542,786.082,563,375.018,415,180.44
  支付其他与筹资活动有关的现金258,597,451.5282,672,626.1330,291,022.69245,520,414.9
  筹资活动现金流出小计725,728,061.56475,915,412.21230,554,397.7654,935,595.34
  筹资活动产生的现金流量净额-33,140,240.56-65,915,412.21-60,554,397.7141,144,404.66
四、汇率变动对现金及现金等价物的影响-2,347,103.42-1,555,462.31-1,106,513.25-6,409,837.1
五、现金及现金等价物净增加额-11,887,989.33-126,569,773.227,561,117.26-20,728,701.58
  加:期初现金及现金等价物余额489,909,024.78489,909,024.78489,909,024.78510,637,726.36
  期末现金及现金等价物余额478,021,035.45363,339,251.56497,470,142.04489,909,024.78
补充资料:
  净利润-28,810,557.54--392,626,872.67
  资产减值准备--1,908,417.18-261,135,938.67
  固定资产和投资性房地产折旧-76,223,717.64-168,736,391.72
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-76,223,717.64-168,736,391.72
  无形资产摊销-11,025,411.4-22,764,864.25
  长期待摊费用摊销-1,700,062.25-3,454,583.57
  处置固定资产、无形资产和其他长期资产的损失--323,099.98--198,252.71
  固定资产报废损失-251,262.87--
  公允价值变动损失-2,979,757.81--419,800
  财务费用-6,158,392.89-15,740,953.25
  投资损失--2,896,732.49-55,457,681.43
  递延所得税-1,451,124.61-2,290,798.66
  其中:递延所得税资产减少-1,926,820.89-1,591,118.99
    递延所得税负债增加--475,696.28-699,679.67
  存货的减少--26,109,504.88-66,643,804.28
  经营性应收项目的减少--27,668,358.72--21,891,982.92
  经营性应付项目的增加-2,727,597.77--35,606,779.41
  其他--30,258,886.21-15,353,763.85
  现金的期末余额-363,339,251.56-489,909,024.78
  减:现金的期初余额-489,909,024.78-510,637,726.36
  现金及现金等价物的净增加额--126,569,773.22--20,728,701.58
公告日期2025-10-302025-08-282025-04-232025-04-23
审计意见(境内)标准无保留意见
TOP↑